# RelayPro Thoracic Stent-Graft in Subjects With Thoracic Aortic Aneurysms and Penetrating Atherosclerotic Ulcers

Study · id `cardio:ct-nct02818972` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02818972](<https://clinicaltrials.gov/study/NCT02818972>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT02818972

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 110 participants.

## Technical summary

Registry record NCT02818972. Allocation not applicable; no masking; primary purpose treatment. Start 2017-05-10 (actual); primary completion 2022-06-24 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 110 participants (planned count; ClinicalTrials.gov record NCT02818972, source copy `cardio:ctgov-nct02818972-2025-05-31`, retrieved 2026-11-18)
- Started: 2017-05-10 (actual) (ClinicalTrials.gov record NCT02818972, source copy `cardio:ctgov-nct02818972-2025-05-31`, retrieved 2026-11-18)
- Primary completion: 2022-06-24 (actual) (ClinicalTrials.gov record NCT02818972, source copy `cardio:ctgov-nct02818972-2025-05-31`, retrieved 2026-11-18)
- Completion: 2025-12 (anticipated) (ClinicalTrials.gov record NCT02818972, source copy `cardio:ctgov-nct02818972-2025-05-31`, retrieved 2026-11-18)
- Countries: United States; Japan (ClinicalTrials.gov record NCT02818972, source copy `cardio:ctgov-nct02818972-2025-05-31`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02818972-2025-05-31`, retrieved 2026-11-18)

## The registry's words

- Brief title: RelayPro Thoracic Stent-Graft in Subjects With Thoracic Aortic Aneurysms and Penetrating Atherosclerotic Ulcers
- Acronym: RelayPro-A
- Condition: Aortic Aneurysm, Thoracic
- Condition: Penetrating Ulcer
- Intervention (Device): RelayPro
- Lead sponsor: Bolton Medical
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic aneurysm (`cardio:aortic-aneurysm`)
- Registry condition terms include this condition: Thoracic aortic aneurysm (`cardio:thoracic-aortic-aneurysm`)
- Registry lists this organization as the lead sponsor: Bolton Medical (`cardio:org-bolton-medical`)

## Provenance

Content hash: 59a9e1dffb831ee82e3783c02f69379aa944df3d1d4bd8e4b250d55134307160
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
